DATHYRCA guidelines - Dahanca
DATHYRCA guidelines - Dahanca
DATHYRCA guidelines - Dahanca
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Guidelines - Thyreoideacancer – revideret oktober 2005<br />
of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal,<br />
in thyroid cancer patients. J.Clin.Endocrinol.Metab 2003;88:1107-11.<br />
121. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C et al. Recombinant human thyrotropin-stimulated<br />
serum thyroglobulin combined with neck ultrasonography has the highest sensitivity<br />
in monitoring differentiated thyroid carcinoma. J.Clin.Endocrinol.Metab 2003;88:3668-73.<br />
122. Goolden AW, Kam KC, Fitzpatrick ML, Munro AJ. Oedema of the neck after ablation of the thyroid<br />
with radioactive iodine. Br.J.Radiol. 1986;59:583-6.<br />
123. Cerletty JM, Listwan WJ. Hyperthyroidism due to functioning metastatic thyroid carcinoma. Precipitation<br />
of thyroid storm with therapeutic radioactive iodine. JAMA 1979;242:269-70.<br />
124. Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma:<br />
concise communication. J.Nucl.Med. 1984;25:755-8.<br />
125. Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients<br />
treated with radioiodine. Int.J.Radiat.Oncol.Biol.Phys. 1996;35:535-40.<br />
126. Leeper RD, Shimaoka K. Treatment of metastatic thyroid cancer. Clin.Endocrinol.Metab 1980;9:383-<br />
404.<br />
127. Keldsen N, Mortensen BT, Hansen HS. Haematological effects from radioiodine treatment of thyroid<br />
carcinoma. Acta Oncol. 1990;29:1035-9.<br />
128. Sarkar SD, Beierwaltes WH, Gill SP, Cowley BJ. Subsequent fertility and birth histories of children and<br />
adolescents treated with 131I for thyroid cancer. J.Nucl.Med. 1976;17:460-4.<br />
129. Schlumberger M, De Vathaire F, Ceccarelli C, Delisle MJ, Francese C, Couette JE et al. Exposure to<br />
radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.<br />
J.Nucl.Med. 1996;37:606-12.<br />
130. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ, Jr. Effects of thyroxine as compared with<br />
thyroxine plus triiodothyronine in patients with hypothyroidism. N.Engl.J.Med. 1999;340:424-9.<br />
131. Romijn JA, Smit JW, Lamberts SW. Intrinsic imperfections of endocrine replacement therapy.<br />
Eur.J.Endocrinol. 2003;149:91-7.<br />
132. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and<br />
carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J.Nucl.Med. 1995;36:21-7.<br />
133. Brincker H, Hansen HS, Andersen AP. Induction of leukemia by 131-I treatment of thyroid carcinoma.<br />
Br.J.Cancer 1973;28:232-7.<br />
134. Pochin EE. Letter: Alcohol and cancer of breast and thyroid. Lancet 1976;1:1137.<br />
135. Hall P, Holm LE, Lundell G. Second primary tumors following thyroid cancer. A Swedish recordlinkage<br />
study. Acta Oncol. 1990;29:869-73.<br />
136. Harmer CL. External beam radiotherapy for thyroid cancer. Ann.Radiol.(Paris) 1977;20:791-800.<br />
137. Sheline GE, Galante M, Lindsay S. Radiation therapy in the control of persistent thyroid cancer.<br />
Am.J.Roentgenol.Radium.Ther.Nucl.Med. 1966;97:923-30.<br />
138. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid<br />
57
Change language